ALS Center of Excellence https://www.umich-als.org Pranger ALS Clinic Tue, 23 May 2023 19:03:02 +0000 en-US hourly 1 https://wordpress.org/?v=6.3.2 https://www.umich-als.org/wp-content/uploads/2019/11/cropped-download-32x32.png ALS Center of Excellence https://www.umich-als.org 32 32 159626766 10 Key Facts About ALS in 2023 https://www.umich-als.org/10-key-facts-about-als-in-2023/ Mon, 08 May 2023 17:54:29 +0000 https://www.umich-als.org/?p=2002 Last year, Dr. Eva Feldman published a seminal ALS seminar in the top academic journal The Lancet.  In honor of ALS Awareness Month (May), she pulled out the ten key facts that are important to know in 2023.  Some even surprise some researchers and clinicians.

1.  There are multiple types of ALS.

They are based on the body parts the disease affects when it initially shows up. Bulbar and Spinal are the two most common forms.  Bulbar onset initially affects the muscles controlling speech and swallowing.  Spinal onset initially affects muscles controlling the arms and legs.  There are several additional less common subtypes of ALS.

Figures 1 A & B from Dr. Feldman’s ALS Seminar in The Lancet

 

The Lancet, Figure 1 A: a schematic showing UMNs (blue), which relay signals from the motor cortex to the LMNs (yellow), which relay signals to the muscles.

The Lancet, Figure 1 A: a schematic showing UMNs (blue), which relay signals from the motor cortex to the LMNs (yellow), which relay signals to the muscles.

2.  At the cellular level, ALS is characterized by degeneration of upper and/or lower motor neurons (nerve cells control muscle contraction).

Upper motor neurons connect the brain to the spinal cord, whereas lower motor neurons connect the spinal cord to the muscles.

3.  ALS is progressive and fatal 100% of the time.

Muscle weakness spreads from the initial onset to neighboring muscles, and so forth. This continues until patients are unable to swallow and eventually breathe.  The progression of ALS is very individual to each patient.

The Lancet, Figure 4 A: King's staging of ALS, which rates the progression of the disease into four stages

The Lancet, Figure 4 A: King’s staging of ALS, which rates the progression of the disease into four stages

4. In addition to muscle weakness, up to 50% of patients with ALS can also present with changes in cognition and behavior.

These cognitive and behavioral changes support the concept that amyotrophic lateral sclerosis is a global neurodegenerative disease along the same continuum as frontotemporal dementia.

The Lancet, Figure 1 C: amyotrophic lateral sclerosis occurs on a continuum with frontotemporal dementia

The Lancet, Figure 1 C: amyotrophic lateral sclerosis occurs on a continuum with frontotemporal dementia

5. ALS is put into two categories based on family history.

Familial ALS occurs in patients with a family history of the disease (about 15% of cases), ALS can also occur in patients without a family history of the disease, called “sporadic ALS

The Lancet, Figure 4 C: a schematic overview of factors that affect amyotrophic lateral sclerosis risk (onset) and prognosis

The Lancet, Figure 4 C: a schematic overview of factors that affect amyotrophic lateral sclerosis risk (onset) and prognosis

6.  There are over 40 known ALS genes.

The most common mutations are to genes C9orf72SOD1TARDBP, and FUS. About 70% of familial and 15% of sporadic ALS cases are associated with a mutation to a known ALS gene.

7.  Environmental and occupational hazards are believed to have an impact on ALS risk and progression.

Veterans have a higher-than-normal rate of ALS.  Last year, we found that production occupations have a higher risk of ALS due to exposure to toxins.

8.  What exactly happens in the body that causes ALS is not completely understood.

However, research suggests that ALS impairs multiple cellular processes, including RNA, protein, and mitochondrial metabolism, trafficking (movement of cargo within neurons), DNA repair, and inflammation.

The Lancet, Figure 3: An ALS differential diagnosis chart

The Lancet, Figure 3: An ALS differential diagnosis chart

9.  ALS is incurable.

Treatment is focused on managing symptoms and strategies to improve quality of life. Therapies that can potentially lengthen life in some patients include riluzole, edaravone, non-invasive ventilation, and gastrostomy tube (feeding tube). Research is actively seeking and testing novel therapies.

10.  We believe that we can one day make ALS a preventable disease.

(not in The Lancet)

The Lancet ALS Seminar in Full

]]>
2002
Journal Cover Features Latest ALS Research https://www.umich-als.org/journal-cover-features-latest-als-research/ Mon, 27 Mar 2023 18:54:44 +0000 https://www.umich-als.org/?p=2035 A team led by Pranger ALS Clinic Director Stephen Goutman, M.D., M.S., and Director of both the ALS Center of Excellence and NeuroNetwork for Emerging Therapies Eva Feldman, M.D., Ph.D., recently published a study in the academic journal Muscle & Nerve that looked at whether body mass index (BMI) is associated with ALS Survival.  The journal not only published the findings but featured them on its March 2023 cover.

Muscle & Nerve’summary of the paper in “Issue Highlights:”

3 BODY MASS INDEX ASSOCIATES WITH AMYOTROPHIC LATERAL SCLEROSIS SURVIVAL AND METABOLOMIC PROFILES (PAGE 208)

Weight loss early in the course of amyotrophic lateral sclerosis (ALS) is associated with shorter survival. This study assessed changes in body mass index (BMI) in individuals with ALS prior to the development of symptoms, and found that BMI decreased by more than 25% in the 10 years preceding the diagnosis of ALS, and that most of this occurred in the 5 years prior to diagnosis. They also found relationships between BMI, BMI trends, and survival. Certain metabolomic profiles were associated with BMI trajectories. An accompanying editorial by Drs. Dupuis and Chio reviews the complex and sometimes contradictory literature on BMI and ALS, and discusses the metabolomic profiles identified in the current paper.

READ THE FULL PAPER ]]>
2035
ALS Risk Higher Among Production Workers https://www.umich-als.org/als-risk-higher-among-production-workers/ Fri, 16 Sep 2022 15:36:12 +0000 https://www.umich-als.org/?p=1927 Michigan Medicine’s Health Lab’s Lab Report shared a recent study by Stephen Goutman, M.D., that found that ALS risk is higher among production workers, those exposed to metals, and volatile compounds on the job due to Michigan’s legacy industry and agriculture.

logo of Michigan Medicine's Michigan Health blog

LAB REPORT:

ALS risk higher among production workers, those exposed to metals, volatile compounds on job

Michigan’s legacy industry and agriculture have led to persistent environmental exposures.

 

Getty Images

In the 150 years since ALS, or amyotrophic lateral sclerosis, first came to scientific light, there remains no cure for the progressive, fatal neurodegenerative condition. But more research continues to uncover environmental contaminants’ insidious role in disease development.

Pesticides and carcinogenic compounds have been found at elevated levels in the blood of patients with ALS, which is also known as Lou Gehrig’s disease. And one study works backwards, finding that those working in “production” – fields such as manufacturing, welding and chemical operation – who are exposed to hazardous chemicals on the job, may have increased risk of developing ALS.

A research team at Michigan Medicine surveyed 381 patients with ALS and 272 control participants to analyze self-reported occupational exposures from their four most recent and longest-held jobs. They found that ALS participants reported higher occupational exposure to metals, particulate matter, volatile organic compounds and combustion pollutants prior to diagnosis. In addition, those working in production occupations had a higher risk of ALS. Results are published in Interventional Archives of Occupational and Environmental Health.

photo of Dr. Stephen Goutman

“This study shows that certain occupational settings and exposures increase one’s chances of developing ALS,” said first author Stephen Goutman, M.D., M.S., director of the Pranger ALS Clinic and associate director of the ALS Center of Excellence at University of Michigan.

“We have known for some time that certain pollutants can increase ALS risk, but identifying where these exposures are occurring is important as we begin to think about strategies for ALS prevention and studying populations of individuals at high disease risk.”

Investigators used a combined approach of patient self-reported occupational exposures and job histories, which were evaluated by exposure scientists. Exposure to metals was most strongly linked to ALS, with iron and welding fume exposure among the most common.

Researchers say this is unsurprising as people in jobs with higher metal exposure, particularly in manufacturing and trade industries, are often exposed to mixtures that may also contain particulate matter, like silica, and volatile organic compounds, such as formaldehyde.

“Some of these workers who later developed ALS may have been exposed to mixtures of metals and other chemicals without their knowledge,” Goutman said. “This should lead our research to investigate these mixtures and the resulting injuries to the central nervous system, or what we refer to as the ALS exposome.”

“Treating this disease once it starts is difficult and thus it is critical that we focus our efforts on prevention.”
— Eva Feldman, M.D., Ph.D.

It is estimated that almost 10 in 100,000 Americans have ALS, according to the Centers for Disease Control and Prevention. The Midwest has the highest rate of the condition, which often begins with muscle weakness, slurred speech or difficulty swallowing.

The FDA has approved two medications to treat ALS, riluzole and edaravone, both of which have shown minimal effectiveness at slowing disease progression. Patients can also receive non-invasive ventilation, a therapy involving a mask worn over the nose to make breathing easier.

“I have spent my 30-year career on evaluating and treating individuals living with ALS,” said senior author Eva Feldman, M.D., Ph.D., director of the ALS Center of Excellence at U-M and James W. Albers Distinguished Professor of Neurology at U-M Medical School.

“ALS remains a disease without an effective treatment.  Studies such as ours are critical in identifying modifiable disease factors and populations at risk so that we can prevent ALS from occurring in the first place.”

Additional authors include Jonathan Boss B.S., M.S., Christopher Godwin, D.D.S, Ph.D., Bhramar Mukherjee, Ph.D. and Stuart Batterman, Ph.D., all of University of Michigan.

“Associations of self-reported occupational exposures and settings to ALS: a case – control study,” International Archives of Occupational and Environmental Health. DOI: 10.1007/s00420-022-01874-4

]]>
1927
Multidisciplinary Team Publishes Paper on ALS Occupational Risk https://www.umich-als.org/multidisciplinary-team-publishes-paper-on-als-occupational-risk/ Fri, 20 May 2022 16:11:38 +0000 https://www.umich-als.org/?p=1910

A robust partnership among the NeuroNetwork for Emerging Therapies, the ALS Center of Excellence, and the University of Michigan School of Public Health has produced an important publication in the International Archives of Occupational and Environmental Health, entitled “Associations of self‑reported occupational exposures and settings to ALS: a case-control study.”

The Background:

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that attacks motor neurons. There are currently no effective treatments, and the disease results in death approximately two to four years after diagnosis.

Approximately 85% of ALS is considered sporadic, meaning there is no single gene mutation underlying the disorder. While the full picture of what causes this form of ALS is incomplete, a combination of genetic and environmental factors are believed to drive disease risk and progression (Goutman 2017).  Researchers know that if they could identify those environmental exposures, they would be able to take a critical step to understand the disease and point to specific exposures that should be avoided to decrease ALS risk disease (Goutman and Feldman 2020).

Previous Research:

The team’s previous research has shown that residential pesticide exposure and concentrations of persistent organic pollutants in the blood are associated with higher risks of developing ALS (Su et al.

2016; Yu et al. 2014). Its studies have also shown that higher concentrations of these persistent organic pollutants in the blood are associated with faster disease progression. (Goutman et al. 2019).

It’s clear that occupational setting is an important exposure factor, and exposures to certain materials have been associated with increased ALS risk (Visser et al. 2019; Malek et al. 2014; Dickerson et al. 2019). These findings have aided researchers in identifying certain occupational sectors with increased ALS risk, including the manufacturing, mechanical, military, painting, precision metal, and construction industries (Andrew et al. 2020, 2017; Fang et al. 2009).  The next step is to identify which occupations are at higher ALS risk, along with the job- and task-specific exposures that increase this risk.

The Team from the NeuroNetwork for Emerging Therapies:

  • Eva Feldman, MD, PhD, Director, ALS Center of Excellence
  • Stephen Goutman, MD, Director of the Pranger ALS
  • Stuart Batterman, PhD, Professor of Environmental Sciences and Global Public Health, School of Public Health
  • Bhramar Mukherjee, PhD, Chair of Biostatistics and Professor of Epidemiology and Global Health, School of Public Health
  • Jonathan Boss, doctoral student, School of Public Health
  • Christopher Godwin, lab technician, School of Public Health.

This Study:

The research team sought to “identify occupational exposures that are associated with a higher risk of ALS using both survey and standard occupational classification (SOC) coding procedures.”

ALS participants and neurologically healthy controls recruited in Michigan completed a detailed exposure assessment based on their four most recent and longest-held occupations. Exposure scores were generated from this survey, and occupations were assigned to SOC codes by experienced exposure scientists.

The study reported that ALS participants experienced higher occupational exposure to particulate matter, volatile organic compounds metals, and combustion and diesel exhaust pollutants prior to their ALS diagnosis when adjusted for sex, age, and military service as compared to control subjects. Work in “production occupations” was also associated with a higher ALS risk.

“Understanding these non-genetic ALS risk factors is critically important to identify factors that increase disease risk, underlying mechanisms, and potential preventative strategies,” explained Dr. Goutman. “Our goal is to one day make ALS a preventable disease.”

]]>
1910